Heart rate variability in premenstrual dysphoric disorder

Psychoneuroendocrinology

Volumn 29, Issue 6, 2004, Pages 733-740

  Landén, Mikael ^a,d   Wennerblom, Bertil ^b   Tygesen, Hans ^b,c   Modigh, Kjell ^a   Sörvik, Karin ^a   Ysander, Christina ^a   Ekman, Agneta ^a   Nissbrandt, Hans ^a   Olsson, Marie ^a   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Southern Älvsborg's Hospital   (Sweden)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Autonomic nervous system; Heart rate; Paroxetine; Premenstrual syndrome; Serotonin uptake inhibitors

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HEART RATE VARIABILITY; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RR INTERVAL; STATISTICAL SIGNIFICANCE; VAGUS NERVE STIMULATION; VAGUS TONE;

ADULT; AUTONOMIC NERVOUS SYSTEM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLICULAR PHASE; HEART; HEART RATE; HUMANS; LUTEAL PHASE; MATCHED-PAIR ANALYSIS; PAROXETINE; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 11144358147     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00117-3     Document Type: Article

References (77)

1. Agelink M.W., Majewski T., Wurthmann C., Postert T., Linka T., Rotterdam S., Klieser E. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. J Affect Disord. 62:2001;187-198.
2. Akselrod S., Gordon D., Madwed J.B., Snidman N.C., Shannon D.C., Cohen R.J. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol. 249:1985;H867-H875.
3. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Berger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 213:1981;220-222.
4. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, fourth ed. Washington, DC: APA.
5. Berntson G.G., Bigger J.T. Jr., Eckberg D.L., Grossman P., Kaufmann P.G., Malik M., Nagaraja H.N., Porges S.W., Saul J.P., Stone P.H., van der Molen M.W. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology. 34:1997;623-648.
6. Bigger J.T. Jr., Kleiger R.E., Fleiss J.L., Rolnitzky L.M., Steinman R.C., Miller J.P. Components of heart rate variability measured during healing of acute myocardial infarction. Am J Cardiol. 61:1988;208-215.
7. Björntorp P. The android woman - a risky condition. J Intern Med. 239:1996;105-110.
8. Boutcher S.H., Stein P. Association between heart rate variability and training response in sedentary middle-aged men. Eur J Appl Physiol. 70:1995;75-80.
9. Cacioppo J.T., Berntson G.G., Binkley P.F., Quigley K.S., Uchino B.N., Fieldstone A. Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology. 31:1994;586-598.
10. Dalack G.W., Roose S.P. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry. 51:(Suppl):1990;4-9. discussion 10-11.
11. Deckert J., Catalano M., Heils A., Di Bella D., Friess F., Politi E., Franke P., Nothen M.M., Maier W., Bellodi L., Lesch K.P. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet. 7:1997;45-47.
12. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol. 14:(Suppl 2):1999;S27-S33.
13. Eryonucu B., Bilge M., Guler N., Uygan I. The effect of autonomic nervous system activity on exaggerated blood pressure response to exercise: evaluation by heart rate variability. Acta Cardiol. 55:2000;181-185.
14. Ewing D.J. Heart rate variability: an important new risk factor in patients following myocardial infarction. Clin Cardiol. 14:1991;683-685.
15. Facchinetti F., Romano G., Fava M., Genazzani A.R. Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med. 54:1992;288-296.
16. Facchinetti F., Tarabusi M., Nappi G. Premenstrual syndrome and anxiety disorders: a psychobiological link. Psychother Psychosom. 67:1998;57-60.
17. Freeman E.W., Halbreich U. Premenstrual syndromes. Psychopharmacol Bull. 34:1998;291-295.
18. Friedman B.H., Thayer J.F. Autonomic balance revisited: panic anxiety and heart rate variability. J Psychosom Res. 44:1998;133-151.
19. Gorman J.M., Fyer A.F., Gliklich J., King D., Klein D.F. Effect of sodium lactate on patients with panic disorder and mitral valve prolapse. Am J Psychiatry. 138:1981;247-249.
20. Gorman J.M., Sloan R.P. Heart rate variability in depressive and anxiety disorders. Am Heart J. 140:2000;77-83.
21. Grossman P., Kollai M. Respiratory sinus arrhythmia, cardiac vagal tone, and respiration: within- and between-individual relations. Psychophysiology. 30:1993;486-495.
22. Guinjoan S.M., Bernabo J.L., Cardinali D.P. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry. 59:1995;299-302.
23. Hamilton S.P., Heiman G.A., Haghighi F., Mick S., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., Knowles J.A. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet. 9:1999;1-6.
24. Hedelin R., Kentta G., Wiklund U., Bjerle P., Henriksson-Larsen K. Short-term overtraining: effects on performance, circulatory responses, and heart rate variability. Med Sci Sports Exerc. 32:2000;1480-1484.
25. Ishiguro H., Arinami T., Yamada K., Otsuka Y., Toru M., Shibuya H. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry Clin Neurosci. 51:1997;333-335.
26. Kleiger R.E., Miller J.P., Bigger J.T. Jr., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59:1987;256-262.
27. Kleiger R.E., Stein P.K., Bosner M.S., Rottman J.N. Time domain measurements of heart rate variability. Cardiol Clin. 10:1992;487-498.
28. Kristal-Boneh E., Raifel M., Froom P., Ribak J. Heart rate variability in health and disease. Scand J Work Environ Health. 21:1995;85-95.
29. La Rovere M.T., Bigger J.T. Jr., Marcus F.I., Mortara A., Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 351:1998;478-484.
30. Landén, M., Eriksson, E. 2003. How does premenstrual dysphoria disorder relate to depression and anxiety disorders? J Anxiety Disord (in press).
31. Leitch J.W., Newling R.P., Basta M., Inder K., Dear K., Fletcher P.J. Randomized trial of a hospital-based exercise training program after acute myocardial infarction: cardiac autonomic effects. J Am Coll Cardiol. 29:1997;1263-1268.
32. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
33. Lindqvist A. Noninvasive methods to study autonomic nervous control of circulation. Acta Physiol Scand. 588:(Suppl):1990;1-107.
34. Loimaala A., Huikuri H., Oja P., Pasanen M., Vuori I. Controlled 5-mo aerobic training improves heart rate but not heart rate variability or baroreflex sensitivity. J Appl Physiol. 89:2000;1825-1829.
35. Malliani A., Pagani M., Lombardi F., Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 84:1991;482-492.
36. Martinez J.M., Kent J.M., Coplan J.D., Browne S.T., Papp L.A., Sullivan G.M., Kleber M., Perepletchikova F., Fyer A.J., Klein D.F., Gorman J.M. Respiratory variability in panic disorder. Depress Anxiety. 14:2001;232-237.
37. McCraty R., Atkinson M., Tomasino D., Stuppy W.P. Analysis of twenty-four hour heart rate variability in patients with panic disorder. Biol Psychol. 56:2001;131-150.
38. Melke J., Landén M., Baghei F., Rosmond R., Holm G., Björntorp P., Westberg L., Hellstrand M., Eriksson E. Serotonin transporter gene polymorphisms are associated with anxiety- related personality traits in women. Am J Med Genet. 105:2001;458-463.
39. Melke J., Westberg L., Landén M., Sundblad C., Eriksson O., Baghei F., Rosmond R., Eriksson E., Ekman A. Serotonin transporter gene polymorphisms and platelet [(3)H] paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinology. 28:2003;446-458.
40. Merikangas K.R., Foeldenyi M., Angst J. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci. 243:1993;23-32.
41. Moser M., Lehofer M., Hoehn-Saric R., McLeod D.R., Hildebrandt G., Steinbrenner B., Voica M., Liebmann P., Zapotoczky H.G. Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J Affect Disord. 48:1998;115-124.
42. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 55:1998;580-592.
43. Pearlstein T., Stone A.B. Premenstrual syndrome. Psychiatr Clin North Am. 21:1998;577-590.
44. Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 58:2001;221-227.
45. Pigozzi F., Alabiso A., Parisi A., Di Salvo V., Di Luigi L., Spataro A., Iellamo F. Effects of aerobic exercise training on 24 hr profile of heart rate variability in female athletes. J Sports Med Phys Fitness. 41:2001;101-107.
46. Pomeranz B., Macaulay R.J., Caudill M.A., Kutz I., Adam D., Gordon D., Kilborn K.M., Barger A.C., Shannon D.C., Cohen R.J., Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 248:1985;H151-H153.
47. Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol. 14:1994;392-395.
48. Rechlin T. [Effects of psychopharmacologic therapy on heart rate variation]. Nervenarzt. 66:1995;678-685.
49. Rechlin T., Weis M., Spitzer A., Kaschka W.P. Are affective disorders associated with alterations of heart rate variability? J Affect Disord. 32:1994;271-275.
50. Rich M.W., Saini J.S., Kleiger R.E., Carney R.M., teVelde A., Freedland K.E. Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol. 62:1988;714-717.
51. Rifkin A. Panic disorder: response to sodium lactate, and treatment with antidepressants. Psychopharmacol Bull. 19:1983;432-434.
52. Saeki Y., Atogami F., Takahashi K., Yoshizawa T. Reflex control of autonomic function induced by posture change during the menstrual cycle. J Auton Nerv Syst. 66:1997;69-74.
53. Sandberg D., Endicott J., Harrison W., Nee J., Gorman J. Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatry Res. 46:1993;79-88.
54. Sato N., Miyake S., Akatsu J., Kumashiro M. Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle. Psychosom Med. 57:1995;331-335.
55. Sattler H.D., Richter P., Fritzsche M., von Turner A., Barnett W. Neurophysiologic tests during antidepressive treatment - an exploratory study. Pharmacopsychiatry. 33:2000;229-233.
56. Sheehan, D.V., Lecrubier, Y. 1998. Mini International Neuropsychiatric Interview. In: www.medical-outcomes.com.
57. Sloan R.P., Shapiro P.A., Bigger J.T. Jr., Bagiella E., Steinman R.C., Gorman J.M. Cardiac autonomic control and hostility in healthy subjects. Am J Cardiol. 74:1994;298-300.
58. Stein P.K., Carney R.M., Freedland K.E., Skala J.A., Jaffe A.S., Kleiger R.E., Rottman J.N. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res. 48:2000;493-500.
59. Steiner M., Born L. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol. 15:(Suppl 3):2000;S5-S17.
60. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. 1996. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93, 1043-1065.
61. Tucker P., Adamson P., Miranda R. Jr., Scarborough A., Williams D., Groff J., McLean H. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol. 17:1997;370-376.
62. Tulen J.H., Bruijn J.A., de Man K.J., Pepplinkhuizen L., van den Meiracker A.H., Man in 't Veld A.J. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J Clin Psychopharmacol. 16:1996;135-145.
63. Tygesen H. Heart Rate Variability in Heart Disease - Evaluation of Cardiac Sympathetic Modulation and Modification by Interventions. 1999;Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Göteborg, Sweden.
64. Tygesen H., Claes G., Drott C., Emanuelsson H., Lomsky M., Lurje L., Radberg G., Wennerblom B., Wettervik C. Effect of endoscopic transthoracic sympathicotomy on heart rate variability in severe angina pectoris. Am J Cardiol. 79:1997;1447-1452.
65. Tygesen H., Wettervik C., Claes G., Drott C., Emanuelsson H., Solem J., Lomsky M., Radberg G., Wennerblom B. Long-term effect of endoscopic transthoracic sympathicotomy on heart rate variability and QT dispersion in severe angina pectoris. Int J Cardiol. 70:1999;283-292.
66. Wettervik C., Claes G., Drott C., Emanuelsson H., Lomsky M., Radberg G., Tygesen H. Endoscopic transthoracic sympathicotomy for severe angina. Lancet. 345:1995;97-98.
67. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., Kuhn C.M., Lewis J.G., Schanberg S.M., Stafford-Smith M., Suarez E.C., Clary G.L., Svenson I.K., Siegler I.C. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med. 63:2001;300-305.
68. Wittchen H.U., Becker E., Lieb R., Krause P. Prevalence incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 32:2002;119-132.
69. Yeragani V.K. Major depression and long-term heart period variability. Depress Anxiety. 12:2000;51-52.
70. Yeragani V.K., Balon R., Pohl R., Ramesh C., Glitz D., Weinberg P., Merlos B. Decreased R-R variance in panic disorder patients. Acta Psychiatr Scand. 81:1990;554-559.
71. Yeragani V.K., Jampala V.C., Sobelewski E., Kay J., Igel G. Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records. Neuropsychobiology. 40:1999;124-128.
72. Yeragani V.K., Pesce V., Jayaraman A., Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychiatry. 52:2002;418-429.
73. Yeragani V.K., Pohl R., Balon R., Ramesh C., Glitz D., Jung I., Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res. 37:1991;35-46.
74. Yeragani V.K., Pohl R., Jampala V.C., Balon R., Ramesh C., Srinivasan K. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety. 11:2000;126-130.
75. Yonkers K.A. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? J Clin Psychiatry. 58:(Suppl 3):1997;62-67. discussion 68-69.
76. Yonkers K.A. Medical management of premenstrual dysphoric disorder. J Gend Specif Med. 2:1999;55-60.
77. Zaubler T.S., Katon W. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature. Bull Menninger Clin. 60:1996;A12-A38.